Share Price | Livero, Inc. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Livero, Inc. with Similar Stocks

Draft, Inc. (Japan)Birdman, Inc.Aoba-BBT, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

With a growth in Operating Profit of 585.13%, the company declared Very Positive results in Mar 26

The company has declared positive results for the last 4 consecutive quarters
ROCE(HY) Highest at 27.92%
NET SALES(Q) Highest at JPY 1,544.1 MM
OPERATING PROFIT(Q) Highest at JPY 562.45 MM

With ROE of 24.98%, it has a attractive valuation with a 3.65 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

JPY 10,636 Million (Micro Cap)

P/E

15.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.50

Return on Equity

24.98%

Price to Book

3.70

Revenue and Profits:

Net Sales:

1,544 Million

(Quarterly Results - Mar 2026)

Net Profit:

370 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

8.46%

6 Months

-5.84%

1 Year

15.52%

2 Years

36.56%

3 Years

114.62%

4 Years

112.69%

5 Years

0.0%

Livero, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

289.20%

EBIT Growth (5y)

262.08%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.50

Sales to Capital Employed (avg)

1.56

Tax Ratio

29.78%

Dividend Payout Ratio

29.72%

Pledged Shares

Institutional Holding

ROCE (avg)

38.23%

ROE (avg)

9.78%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.65

EV to EBIT

8.91

EV to EBITDA

8.21

EV to Capital Employed

6.34

EV to Sales

1.94

PEG Ratio

0.12

Dividend Yield

ROCE (Latest)

71.25%

ROE (Latest)

24.98%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 69.77% vs -7.50% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 464.73% vs -35.53% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,544.10",
          "val2": "909.50",
          "chgp": "69.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "562.40",
          "val2": "81.80",
          "chgp": "587.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "369.90",
          "val2": "65.50",
          "chgp": "464.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "346.90%",
          "val2": "66.80%",
          "chgp": "28.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 21.69% vs 23.63% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 56.86% vs 226.18% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,364.50",
          "val2": "3,586.50",
          "chgp": "21.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "838.90",
          "val2": "513.80",
          "chgp": "63.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "531.60",
          "val2": "338.90",
          "chgp": "56.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "174.20%",
          "val2": "127.00%",
          "chgp": "4.72%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,544.10

909.50

69.77%

Operating Profit (PBDIT) excl Other Income

562.40

81.80

587.53%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

369.90

65.50

464.73%

Operating Profit Margin (Excl OI)

346.90%

66.80%

28.01%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 69.77% vs -7.50% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 464.73% vs -35.53% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

4,364.50

3,586.50

21.69%

Operating Profit (PBDIT) excl Other Income

838.90

513.80

63.27%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

531.60

338.90

56.86%

Operating Profit Margin (Excl OI)

174.20%

127.00%

4.72%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 21.69% vs 23.63% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 56.86% vs 226.18% in Dec 2024

All Annual Results

Company CV

About Livero, Inc.

Livero, Inc.

Miscellaneous

No Details Available.

Company Coordinates

No Company Details Available